Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200060358Phase 4Recruiting
Phase 4, randomised trial of ciprofol (2 arms), sponsored by Jingzhou First People's Hospital. Primary endpoint: Incidence of perioperative adverse effects. Started May 2022; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200060358.